Jeffrey Molter named director of communications at NYU Perlmutter Cancer Center

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Jeffrey Molter joined NYU Langone Medical Center in a newly-created position of director of cancer center communications of its Laura and Isaac Perlmutter Cancer Center.Molter comes to Perlmutter after serving for the past four years as director of media and public relations for the American Association for Cancer Research in Philadelphia.“Jeff will team up with the Department of Marketing & Communications to plan, implement and manage communication initiatives for our rapidly growing Perlmutter Cancer Center,” said Kathy Lewis, senior vice president for Marketing & Communications at NYU Langone.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe

YOU MAY BE INTERESTED IN

When our hematological malignancy testing pilot project began in Eldoret, Kenya, there seemed to be a mismatch in relation to progress in healthcare. The region, like much of sub-Saharan Africa, had been focusing on combatting infectious diseases such as HIV and malaria—which was much-needed—yet cancer care was under-resourced. 
Artificial intelligence is rapidly transforming biomedical research and healthcare. Large language models, foundation models, and AI agents are increasingly being deployed to assist with data interpretation, literature review, clinical decision support, and translational research. 
In modern oncology, important insights from clinical trials often emerge years after initial publication. As new therapies extend survival and transition more patients into long-term remissions, clinicians and researchers are increasingly looking beyond initial response rates to understand durability, long-term safety, and even the possibility of a cure. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login